Recent Finacing
Recent Raise
ONCOMATRYX is a Spanish biopharmaceutical company developing Quantum ADCs that target cancer-associated fibroblasts in the tumor microenvironment.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Oncomatryx.